Search

Search Constraints

You searched for: Author/Creator Shukuya, Takehito

Search Results

1. A Japanese lung cancer registry study on demographics and treatment modalities in medically treated patients. Issue 5 (25th March 2020)

2. Alectinib versus crizotinib in patients with ALK-positive non-small-cell lung cancer (J-ALEX): an open-label, randomised phase 3 trial. Issue 10089 (1st July 2017)

3. An immunogold single extracellular vesicular RNA and protein (AuSERP) biochip to predict responses to immunotherapy in non‐small cell lung cancer patients. Issue 9 (12th September 2022)

4. CALML5 is a novel diagnostic marker for differentiating thymic squamous cell carcinoma from type B3 thymoma. Issue 12 (16th March 2023)

6. Clinical characteristics of adrenal insufficiency induced by pembrolizumab in non‐small‐cell lung cancer. Issue 5 (15th December 2022)

7. Clinical Outcomes of Second‐Line Chemotherapy in Patients with Previously Treated Advanced Thymic Carcinoma: A Retrospective Analysis of 191 Patients from the NEJ023 Study. (26th November 2019)

8. Corrigendum to: Pattern of care in adjuvant therapy for resected Stage I non-small cell lung cancer: real-world data from Japan. (17th February 2020)

9. Differences in the efficacy of S‐1 monotherapy according to histological type in pretreated patients with advanced non‐small cell lung cancer. Issue 2 (March 2014)

10. Efficacy of Rechallenge Chemotherapy in Patients With Sensitive Relapsed Small Cell Lung Cancer. (February 2015)